BBHC
JAZZ icon

Brown Brothers Harriman & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

Brown Brothers Harriman & Co’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.24K Sell
33
-8
-20% -$1.4K ﹤0.01% 1446
2025
Q4 		$6.97K Buy
+41
New +$6.29K ﹤0.01% 1425
2022
Q3 		– Sell
-650
Closed -$101K – 1544
2022
Q2 		$101K Hold
650
– – ﹤0.01% 577
2022
Q1 		$101K Buy
+650
New +$94.3K ﹤0.01% 631
2021
Q4 		– Sell
-8
Closed -$1 – 1185
2021
Q3 		$1 Sell
8
-4
-33% -$604 ﹤0.01% 1121
2021
Q2 		$2 Buy
12
+8
+200% +$1.39K ﹤0.01% 1072
2021
Q1 		$1 Sell
4
-1,978
-100% -$325K ﹤0.01% 1062
2020
Q4 		$327K Buy
1,982
+176
+10% +$26.2K ﹤0.01% 356
2020
Q3 		$258K Sell
1,806
-362
-17% -$44.9K ﹤0.01% 348
2020
Q2 		$239K Buy
2,168
+2,138
+7,127% +$236K ﹤0.01% 353
2020
Q1 		$3K Buy
+30
New +$3.88K ﹤0.01% 871
2019
Q4 		– Sell
-5
Closed -$1K – 1191
2019
Q3 		$1K Hold
5
– – ﹤0.01% 1126
2019
Q2 		$1K Buy
+5
New +$672 ﹤0.01% 1024
2018
Q1 		– Sell
-45
Closed -$6K – 966
2017
Q4 		$6K Buy
+45
New +$6.24K ﹤0.01% 819
2015
Q4 		– Sell
-17
Closed -$2K – 773
2015
Q3 		$2K Buy
+17
New +$2.93K ﹤0.01% 785
2014
Q3 		– Sell
-2,800
Closed -$412K – 780
2014
Q2 		$412K Sell
2,800
-421
-13% -$58.4K ﹤0.01% 281
2014
Q1 		$447K Buy
3,221
+2,800
+665% +$421K ﹤0.01% 255
2013
Q4 		$53K Sell
421
-179
-30% -$18.5K ﹤0.01% 454
2013
Q3 		$55K Hold
600
– – ﹤0.01% 459
2013
Q2 		$41K Buy
+600
New +$36.7K ﹤0.01% 559

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Brown Brothers Harriman & Co's JAZZ Position: Q1 2026 in Review

Brown Brothers Harriman & Co reduced its Jazz Pharmaceuticals (JAZZ) stake by 20% in Q1 2026, selling an estimated $1.4K and leaving 33 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

Brown Brothers Harriman & Co first reported a position in JAZZ in Q2 2013 and has held it in 20 quarters since. The position peaked at $447K in Q1 2014. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Brown Brothers Harriman & Co held 33 shares of Jazz Pharmaceuticals worth $6.24K as of Q1 2026.
  • Brown Brothers Harriman & Co sold 8 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.4K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q1 2026, its #1446 holding.
  • Brown Brothers Harriman & Co first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
  • Brown Brothers Harriman & Co's Jazz Pharmaceuticals position peaked at $447K in Q1 2014.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.